Dr. James Stevenson

About Dr. James Stevenson

Dr. James Stevenson is a board-certified hematologist and medical oncologist. He’s been in practice for over 20 years and has treated patients with mesothelioma for more than a decade.

He’s currently the Vice Chairman of the Department of Hematology and Medical Oncology at the Cleveland Clinic Taussig Cancer Institute.

“I work with a great multidisciplinary group in the thoracic oncology program. We have active thoracic surgeons experienced in mesothelioma surgery.”
– Dr. James Stevenson, mesothelioma specialist

Dr. Stevenson is a compassionate physician with an excellent bedside manner and exceptional patient reviews.

He also regularly participates in cancer research and clinical trials for immunotherapy treatments that could help mesothelioma patients live longer.

Find top mesothelioma specialists like Dr. Stevenson near you with our Free Doctor Match.

Dr. James Stevenson’s Mesothelioma Treatment Approach

As a medical oncologist, Dr. Stevenson specializes in treating mesothelioma with medications including chemotherapy, immunotherapy, and targeted therapy.

Dr. Stevenson takes a multimodal approach to patient care, using a variety of therapies to fight this cancer. He tailors mesothelioma treatment to each person’s individual diagnosis, age, cancer stage, and other factors.

Notably, he can treat the two most common types of mesothelioma: pleural mesothelioma (cancer of the lung lining) and peritoneal mesothelioma (cancer of the abdominal lining).

Dr. Stevenson frequently works with other specialists like radiation oncologists, thoracic surgeons, pulmonologists, and pathologists to ensure his patients get the most comprehensive care. He also has relationships with palliative care experts for patients in the advanced stages of cancer.

Dr. Stevenson believes in integrating the latest research and medical data into his treatment plans, with a special interest in clinical trials testing new mesothelioma immunotherapy techniques.

Dr. James Stevenson’s Medical Specializations

Dr. Stevenson specializes in treating many types of illnesses and cancers, most notably mesothelioma.

His medical specialties include:

• Blood cancer
• Blood disease
• Carcinoid tumors of the lungs
• Lung cancer
• Lymphoma
• Malignant pleural mesothelioma
• Myeloma
• Peritoneal mesothelioma
• Sarcoma
• Thymic cancers

He also specializes in the following treatments:

• Chemotherapy
• Immunotherapy
• Targeted therapy

Get answers about your diagnosis and treatment plan during your next appointment by downloading our Free Questions to Ask Your Doctor Checklist.

Dr. James Stevenson’s Medical Background

Dr. Stevenson received his undergraduate degree from the University of Notre Dame in 1988.

He followed this with a medical degree from Jefferson Medical College at Thomas Jefferson University in Philadelphia in 1992, then an internship at the University of Florida College of Medicine’s Shands Medical Center the next year.

Dr. Stevenson then returned to Philadelphia and Thomas Jefferson University Hospital, where he completed a residency in internal medicine in 1995 and a fellowship in hematology and medical oncology in 1998.

He joined the team at Cleveland Clinic in 2012 and was later appointed as Vice Chairman of the Department of Hematology and Medical Oncology in 2015.

Dr. Stevenson also plays a significant role at Taussig Cancer Institute’s Multidisciplinary Pleural Mesothelioma Center, where researchers and oncologists are working together to improve the methods used to diagnose mesothelioma.

Highlights of Dr. James Stevenson’s Medical Career

Dr. Stevenson has been consistently recognized by both his patients and members of the medical community.

Awards and Accolades

Dr. Stevenson has received many honors for his commitment to providing the best patient experience for those who visit him at Cleveland Clinic.

These recognitions include:

• 5-Star Rating from Patients
• Castle Connolly, Best Regional Doctors
• Philadelphia Magazine Top Docs

“Dr. Stevenson is a special person. Not only does he possess world-class credentials in the field of oncology, but he had deep, genuine empathy for my predicament. His concern and optimism showed.”
– Patient of Dr. James Stevenson

Professional Affiliations

Dr. Stevenson also holds board certifications, memberships, and licenses related to oncology and mesothelioma.

These affiliations include:

• Board certification in medical oncology by the American Board of Internal Medicine
• Member of the American Society of Clinical Oncology
• Member of the Mesothelioma Applied Research Foundation (Meso Foundation) Board of Directors
• State of Ohio Medical License

Dr. James Stevenson’s Published Works

Dr. Stevenson’s research on mesothelioma and lung cancer has been published in several respected publications.

Some of his most recent contributions include:

• “Mesothelioma: Pleural, Version 1.2024: Featured Updates to the NCCN Guidelines.” Published in the Journal of the National Comprehensive Cancer Network, March 2024.
• “Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.” Published in the Journal of the National Comprehensive Cancer Network, September 2023.
• “Clinical outcomes with pembrolizumab-based therapies in relapsed/refractory NSCLC after definitive chemoradiation and durvalumab.” Published in Cancer Research, April 2023.
• “A phase I study of concurrent neoadjuvant pembrolizumab plus chemoradiation followed by consolidation pembrolizumab in resectable stage IIIA non-small cell lung cancer patients.” Published in JTO Clinical and Research Reports, June 2022.

Use our Free Doctor Match now to connect with leading mesothelioma experts like Dr. Stevenson in your area.

Dr. Stevenson’s Work in Cancer Treatment & Research

Much of Dr. Stevenson’s work in cancer treatment and research has been in the field of immunotherapy.

Immunotherapy is a cancer treatment that uses a patient’s own immune system to fight cancer, and many doctors are feeling optimistic about its benefits for mesothelioma.

By continuing to explore immunotherapy treatments in clinical trials, Dr. Stevenson hopes to improve the prognosis (health outcome) and quality of life of mesothelioma patients.

He’s been particularly encouraged by the results from the CheckMate 743 clinical trial, which revealed that the combination of the immunotherapy drugs Opdivo® and Yervoy® helped patients live an average of 3 months longer than chemotherapy.

“It turns out that as we look closer at [the CheckMate 743] trial, immunotherapy probably works better in some patients than chemotherapy. We don’t interpret this trial as immunotherapy replacing chemotherapy but as an additional treatment.”
– Dr. James Stevenson, mesothelioma specialist

Get Connected to Dr. James Stevenson

A mesothelioma diagnosis can be daunting, but seeking medical care from an experienced mesothelioma doctor can make all the difference.

Dr. James Stevenson is accepting new patients with pleural or peritoneal mesothelioma and can help you access life-changing treatment.

Connect with Dr. Stevenson and other top mesothelioma specialists right now by calling (866) 608-8933 or using our Free Doctor Match.